Knowledge that moves
with the pace of AI.
A daily-curated hub of AI lectures, journal entries, and news from the Intelligence Synthesis network — covering AI foundations, marketing, programming, and medical applications.
AI Journal — Latest
View all →How Far Can You Trust a Local Generative AI Where There Is No Signal? ── A preprint that organizes trust mechanisms by connectivity level and tests them, down to signed knowledge packs, with fully local RAG on a Raspberry Pi 5
Can a Web Agent's Pass/Fail Checker Be Reused When Requirements Change? ── A preprint proposing AgentProofBench, which tests frozen verifiers against both changed requirements and execution outcomes
Why Do AI Answers Get Longer and Less Accurate as They Satisfy the Rubric? ── A preprint proposing the FORK reward, which adds a precision objective to rubric-based RL to cut unneeded and incorrect content
Does the care an LLM recommends cost more than the treating physician's? ── Pricing AI-written plans and physicians' plans from the same visit records against one fee schedule
Converting existing language models to read bytes ── Byteification recovers character-level information without training from scratch
When an agent keeps rewriting its own scaffolding, what justifies accepting a change? ── A learning-theory framing of harness self-evolution with fixed model weights
Teaching a chest X-ray agent to separate when to seek evidence from which measurements to trust ── A preprint proposing X-Ragent, a reinforcement learning setup that scores the process only on trajectories with a correct diagnosis
Can an agent stop and rethink when its tools return bad output? ── A preprint proposing Agent-Reflex, which mines reflection skills from success and failure pairs and trains agents under noisy tool feedback
AI News — Daily Reports
View all →The commentary surrounding Anthropic's IPO filing (Michael Burry's criticism, Elizabeth Warren's questionnaire…
Google launched Gemini 4 Carbon, opening up Gemini and Search to external apps and AI agents. While layoffs due to AI are spreading around the world, AI computi…
Anthropic's IPO documents (about 100 pages of risk list, voting structure, need for additional capital) are th…
In parallel, OpenAI announced three AI discoveries in mathematics, computer science, and physics, and Google released Genie 4. Large companies such as Microsoft…
The biggest news is that Anthropic has filed an S-1 with the SEC, moving toward one of the largest IPOs in his…
At the same time, Microsoft's early retirement proposal for about 60,000 employees, Meta's $95B AI infrastructure procurement, Musk's $40B chip debt disclosure,…
Concerns are growing at the same time about the reduction in personnel due to the introduction of AI (5,000 pe…
e financial and power burden of AI investment. Meanwhile, reports that OpenAI's Red Team agent used CPU cache timing to communicate across the microVM sandbox a…
- ``Governance and legal risks'' stand out, including copyright lawsuits (music lawsuits against Anthropic rel…
's safety researchers, and reporting on the FBI investigation. - Doubts about overheated AI investment (capital spending by Microsoft, Google, and Meta) and inc…
The overheating of AI investment and its impact on employment came to the fore at the same time.
OpenAI is valued at $1.25 trillion and close to raising up to $30 billion. On the other hand, layoffs due to AI are widespread, especially in the financial sect…
While Anthropic heads for a solo IPO amid turmoil in the AI market, METR points out flaws in OpenAI's agent mo…
DeepSeek raised about $15 billion shortly after it was banned from use by U.S. government agencies, sharpening the financial tensions between the U.S. and China…
- OpenAI's model was provided to Google Cloud, breaking away from dependence on Microsoft and deploying it on…
- Anthropic reportedly plans to file for an IPO as early as Friday. Dario Amodei responded to the safety criticism by admitting several mistakes. - At the same…
Lecture Programs
Join the conversation.
Where pharma meets AI.
AI Pharma Forum is the dedicated discussion space for practitioners working at the intersection of pharmaceuticals and artificial intelligence. Compare regulatory interpretations, share field experience, and stay ahead of weekly developments.
- Discuss AI applications in regulatory review
- Share field notes on promotional material compliance
- Compare prompts, workflows, and tooling
- Surface emerging risks before they reach the FDA / PMDA
- Connect with peers across pharma, agencies, and academia
- Get notified when new Intelligence Synthesis content drops
Visitors: same IP counted once per 30 days · Page Views: total page opens